Letter to Stockholders November 14, 2022 Dear Harrow Stockholders: I am pleased to report third quarter results that included 22% year-over-year revenue growth and the company remaining "in the black" while we prepare to launch IHEEZO™, generate new high-value revenues from our portfolio of FDA-approved branded pharmaceutical products (BPPs), and advance our market-leading ImprimisRx compounded pharmaceuticals products (CPPs) brand. Here are a few recent noteworthy events connected to the continued executio ...

Harrow Health, Inc. (NASDAQ:HROW) Q3 2022 Earnings Conference Call November 14, 2022 4:45 PM ET Company Participants Jamie Webb – Director-Communications and Investor Relations Mark L. Baum – Chief Executive Officer Andrew Boll – Chief Financial Officer Conference Call Participants Jeffrey Cohen – Ladenburg Thalmann Sahil Kazmi – B. Riley Operator Good afternoon, and welcome to HarrowÂ's Third Quarter 2022 Earnings Conference Call. My name is Andrea, and IÂ'll be your operator for todayÂ's call. At this tim ...

Harrow Health, Inc. (NASDAQ:HROW) Q2 2022 Earnings Conference Call August 9, 2022 4:45 PM ET Company Participants Jamie Webb - Director of Communications and Investor Relations Mark Baum - Chief Executive Officer and Chairman of the Board Andrew Boll - Chief Financial Officer Conference Call Participants Destiny Buch - Ladenburg Thalmann Sahil Kazmi - B. Riley Securities Nathan Weinstein - Aegis Capital Brooks O'Neil - Lake Street Capital Markets Operator Good afternoon, and welcome to Harrow HealthÂ's Seco ...

Harrow HealthÂ's (NASDAQ:HROW) Q1 2022 Earnings Conference Call May 5, 2022 4:45 PM ET Company Participants Jamie Webb - Director of Communications and Investor Relations Mark Baum - Chief Executive Officer and Chairman of the Board Andrew Boll - Chief Financial Officer Conference Call Participants Destiny Buch - Ladenburg Thalmann Nathan Weinstein - Aegis Capital Sahil Kazmi - B. Riley Securities Operator Good afternoon, and welcome to Harrow HealthÂ's Q1 2022 Earnings Conference Call. My name is Allison, ...

HARROW HEALTH | INC. Corporate Presentation | May 2022 Safe Harbor 2 This presentation contains express "forward-looking statements" as defined in the U.S. Private Securities Litigation Reform Act of 1995. You are cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projecti ...

HARROW HEALTH INC. Corporate Presentation | March 2022 Safe Harbor This presentation contains express "forward-looking statements" as defined in the U.S. Private Securities Litigation Reform Act of 1995. You are cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and projection ...

Harrow Health, Inc. (NASDAQ:HROW) Q4 2021 Earnings Conference Call March 10, 2022 4:45 PM ET Company Participants Jamie Webb – Director-Communications and Investor Relations Mark L. Baum – Chief Executive Officer Andrew Boll – Chief Financial Officer Conference Call Participants Brooks O'Neil – Lake Street Capital Markets. Destiny Buch – Ladenburg Thalmann Justin Walsh – B. Riley Securities Nathan Weinstein – Aegis Capital Shawn Boyd – Next Mark Capital Operator Good afternoon, and welcome to Harrow Health' ...

HARROW HEALTH INC. Corporate Presentation | November 2021 Safe Harbor 2 This presentation contains express "forward-looking statements" as defined in the U.S. Private Securities Litigation Reform Act of 1995. You are cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and proje ...

Harrow Health, Inc. (NASDAQ:HROW) Q3 2021 Earnings Conference Call November 9, 2021 4:45 PM ET Company Participants Jamie Webb – Director of Communications and Investor Relations Mark L. Baum – Chief Executive Officer Andrew Boll – Chief Financial Officer Conference Call Participants Jeffrey Cohen – Ladenburg Thalmann Brian Hollenden – Aegis Capital Operator Good afternoon, and welcome to Harrow HealthÂ's Third Quarter 2021 Earning Conference Call. My name is Aily, and IÂ'll be your operator for todayÂ's ca ...

HARROW HEALTH | INC. Corporate Presentation | August 2021 Safe Harbor 2 This presentation contains express "forward-looking statements" as defined in the U.S. Private Securities Litigation Reform Act of 1995. You are cautioned not to rely on these forward-looking statements. These statements are based on current expectations of future events. If underlying assumptions prove inaccurate or known or unknown risks or uncertainties materialize, actual results could vary materially from the expectations and proje ...